Real-world evidence for frequency of constipation with the use of anti-CGRP monoclonal antibodies in chronic migraine

被引:0
|
作者
Uzun, S. [1 ,2 ]
Frejvall, U. [1 ]
Sahin, G. Ozkaya [3 ,4 ]
Sahin, G. [1 ,2 ]
机构
[1] Skaneuro Neurol Clin, Lund, Sweden
[2] Lund Univ, Dept Clin Sci Malmo & Lund, Lund, Sweden
[3] Lund Univ, Dept Lab Med, Lund, Sweden
[4] Lund Univ, Dept Translat Med, Lund, Sweden
来源
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P015
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine
    Scuteri, Damiana
    Tonin, Paolo
    Nicotera, Pierluigi
    Vulnera, Marilu
    Altieri, Giuseppina Cristina
    Tarsitano, Assunta
    Bagetta, Giacinto
    Corasaniti, Maria Tiziana
    TOXINS, 2022, 14 (08)
  • [22] Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
    Hugo Sevivas
    Paula Fresco
    European Journal of Medical Research, 27
  • [23] Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Caronna, Edoardo
    Gallardo, Victor Jose
    Egeo, Gabriella
    Vazquez, Manuel Millan
    Castellanos, Candela Nieves
    Membrilla, Javier A.
    Vaghi, Gloria
    Rodriguez-Montolio, Joana
    Fabra, Neus Fabregat
    Sanchez-Caballero, Francisco
    Sanchez, Alex Jaimes
    Munoz-Vendrell, Albert
    Oliveira, Renato
    Garate, Gabriel
    Gonzalez-Osorio, Yesica
    Guisado-Alonso, Daniel
    Ornello, Raffaele
    Thunstedt, Cem
    Fernandez-Lazaro, Iris
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Torelli, Paola
    Aurilia, Cinzia
    Pere, Raquel Lamas
    Castrillo, Maria Jose Ruiz
    De Icco, Roberto
    Sances, Grazia
    Broadhurst, Sarah
    Ong, Hui Ching
    Garcia, Andrea Gomez
    Campoy, Sergio
    Sanahuja, Jordi
    Cabral, Goncalo
    Blasco, Isabel Beltran
    Waliszewska-Prosol, Marta
    Pereira, Liliana
    Layos-Romero, Almudena
    Luzeiro, Isabel
    Dorado, Laura
    Escudero, Maria Rocio Alvarez
    May, Arne
    Lopez-Bravo, Alba
    Martins, Isabel Pavao
    Sundal, Christina
    Irimia, Pablo
    Ros, Alberto Lozano
    Gago-Veiga, Ana Beatriz
    Juanes, Fernando Velasco
    Ruscheweyh, Ruth
    Sacco, Simona
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (10): : 927 - 937
  • [24] Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
    Sevivas, Hugo
    Fresco, Paula
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [25] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
    Hennessy, Elise
    Salim, Amira
    Biswas, Sudipa
    Suneja, Aarushi
    Mays, Maryann
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [26] Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
    Sanchez-Rodriguez, Carmen
    Gago-Veiga, Ana Beatriz
    Garcia-Azorin, David
    Guerrero-Peral, Angel Luis
    Gonzalez-Martinez, Alicia
    CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (12) : 1265 - 1272
  • [27] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Amy R. Tso
    Peter J. Goadsby
    Current Treatment Options in Neurology, 2017, 19
  • [28] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Tso, Amy R.
    Goadsby, Peter J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (08)
  • [29] Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
    Iannone, Luigi Francesco
    De Cesaris, Francesco
    Ferrari, Anita
    Benemei, Silvia
    Fattori, Davide
    Chiarugi, Alberto
    CEPHALALGIA, 2022, 42 (13) : 1323 - 1330
  • [30] Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
    Vikelis, Michail
    Rikos, Dimitrios
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Andreou, Anna P.
    Russo, Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2025,